OKUR   $4.385  9.35% Market Closed After Close 4.6906 6.97%

OnKure Therapeutics, Inc.

Current temperature: 14.60
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 5
Target Price Mean 24.80
Mean unverified/preliminary 24.80 / 24.80
Target Price Low / High 17.00 / 30.00
Median / STD DEV 27.00 / 5.59
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total ActivelyBuy ActivelyBuy ActivelyBuy
rsi Buy ActivelyBuy None
macd None None None
stoch None None None
ma20 None ActivelyBuy None
ma50 ActivelyBuy None None
ma100 ActivelyBuy ActivelyBuy ActivelyBuy
Candlestick PatternMarch 12, 2026 Dragon Fly - is formed when the opening and the closing prices are at the highest of the day. If it has a longer lower shadow it signals a more bullish trend. When appearing at market bottoms it is considered to be a reversal signal.
ISIN US68277Q1058
ceo Dr. Nicholas A. Saccomano Ph.D.
Website https://onkuretherapeutics.com
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops biologically validated drivers of cancers medicines in the United States. The company's lead product candidate is the OKI-219, a selective inhibitor of PI3Ka harboring the H1047R mutation for the treatment of solid tumors, including breast cancer that is in Phase 1 clinical trial. OnKure Therapeutics, Inc. is headquartered in Boulder, Colorado.